Compare UK & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UK | GCTK |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 2.5M |
| IPO Year | 2020 | 2011 |
| Metric | UK | GCTK |
|---|---|---|
| Price | $2.15 | $0.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 49.8K | ★ 17.4M |
| Earning Date | 03-24-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.44 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $0.25 |
| 52 Week High | $5.90 | $14.14 |
| Indicator | UK | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 44.01 |
| Support Level | $1.91 | $0.28 |
| Resistance Level | $2.33 | $0.63 |
| Average True Range (ATR) | 0.24 | 0.08 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 31.88 | 6.09 |
Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has two operating segments: Workspace membership, and Other services. The Workspace membership segment generates the majority of the company's revenue.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.